Determining the minimal clinically important difference for the questionnaire of olfactory disorders in people with cystic fibrosis and factors associated with improvement after highly effective modulator therapy

Introduction Olfactory dysfunction (OD) is common among people with cystic fibrosis (PwCF). The Questionnaire of Olfactory Disorders (QOD) is a validated instrument that evaluates olfactory‐specific quality‐of‐life. The QOD minimal clinically important difference (MCID) and factors associated with o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International forum of allergy & rhinology 2024-06, Vol.14 (6), p.1079-1087
Hauptverfasser: Miller, Jessa E., Taylor‐Cousar, Jennifer L., Overdevest, Jonathan B., Khatiwada, Aastha, Mace, Jess C., Alt, Jeremiah A., Bodner, Todd E., Chowdhury, Naweed I., DiMango, Emily A., Eshaghian, Patricia H., Getz, Anne E., Gudis, David A., Han, Ethan J., Hwang, Peter H., Keating, Claire L., Khanwalkar, Ashoke, Kimple, Adam J., Lee, Jivianne T., Li, Douglas, Markarian, Karolin, Norris, Meghan, Nayak, Jayakar V., Owens, Cameran, Patel, Zara M., Poch, Katie, Schlosser, Rodney J., Smith, Kristine A., Smith, Timothy L., Soler, Zachary M., Suh, Jeffrey D., Tervo, Jeremy P., Turner, Grant A., Wang, Marilene B., Saavedra, Milene T., Beswick, Daniel M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!